5-[5-fluoro-6-(pyrrolidin-2-ylmethoxy)-1,3-dihydroisoindol-2-yl]-4-(trifluoromethyl)diazinan-3-one
C18H22F4N4O2 — CID 154825718
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-[5-fluoro-6-(pyrrolidin-2-ylmethoxy)-1,3-dihydroisoindol-2-yl]-4-(trifluoromethyl)diazinan-3-one
5-[5-fluoro-6-(pyrrolidin-2-ylmethoxy)-1,3-dihydroisoindol-2-yl]-4-(trifluoromethyl)diazinan-3-one (PubChem CID 154825718) has the molecular formula C18H22F4N4O2 and a molecular weight of 402.39 g/mol. Its IUPAC name is 5-[5-fluoro-6-(pyrrolidin-2-ylmethoxy)-1,3-dihydroisoindol-2-yl]-4-(trifluoromethyl)diazinan-3-one.
Molecular Properties
| Compound Name | 5-[5-fluoro-6-(pyrrolidin-2-ylmethoxy)-1,3-dihydroisoindol-2-yl]-4-(trifluoromethyl)diazinan-3-one |
|---|---|
| PubChem CID | 154825718 |
| Molecular Formula | C18H22F4N4O2 |
| Molecular Weight | 402.39 g/mol |
| Exact Mass | 402.17 |
| IUPAC Name | 5-[5-fluoro-6-(pyrrolidin-2-ylmethoxy)-1,3-dihydroisoindol-2-yl]-4-(trifluoromethyl)diazinan-3-one |
| SMILES | O=C1NNCC(N2Cc3cc(F)c(OCC4CCCN4)cc3C2)C1C(F)(F)F |
| InChI | InChI=1S/C18H22F4N4O2/c19-13-4-10-7-26(14-6-24-25-17(27)16(14)18(20,21)22)8-11(10)5-15(13)28-9-12-2-1-3-23-12/h4-5,12,14,16,23-24H,1-3,6-9H2,(H,25,27) |
| InChIKey | DBUQOQNCYNOLFZ-UHFFFAOYSA-N |
| XLogP | 1.45 |
| TPSA | 65.63 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 28 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 402.39 |
| LogP ≤ 5 | 1.45 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 154825718 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.